These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 19833629)
1. Early discharge of patients with venous thromboembolism: implications regarding therapy. Stein PD; Hull RD; Matta F; Yaekoub AY Clin Appl Thromb Hemost; 2010 Apr; 16(2):141-5. PubMed ID: 19833629 [TBL] [Abstract][Full Text] [Related]
2. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs. Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC; J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561 [TBL] [Abstract][Full Text] [Related]
3. Outpatient management of anticoagulation therapy. du Breuil AL; Umland EM Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618 [TBL] [Abstract][Full Text] [Related]
4. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation. Huse DM; Cummins G; Taylor DC; Russell MW Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346 [TBL] [Abstract][Full Text] [Related]
5. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience]. Míka P; Behounek J; Skoták M; Nevsímal L Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102 [TBL] [Abstract][Full Text] [Related]
6. Expedited discharge in trauma patients requiring anticoagulation for deep venous thrombosis prophylaxis: the LEAP Program. Bridges GG; Lee MD; Jenkins JK; Stephens MA; Croce MA; Fabian TC J Trauma; 2003 Feb; 54(2):232-5. PubMed ID: 12579045 [TBL] [Abstract][Full Text] [Related]
7. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement. Bell GK; Goldhaber SZ Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156 [TBL] [Abstract][Full Text] [Related]
8. Economic and utilization outcomes associated with choice of treatment for venous thromboembolism in hospitalized patients. Knight KK; Wong J; Hauch O; Wygant G; Aguilar D; Ofman JJ Value Health; 2005; 8(3):191-200. PubMed ID: 15877591 [TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of 20 pregnant women with venous thromboembolic disease]. Sun P; Dong DN Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):911-6. PubMed ID: 22333281 [TBL] [Abstract][Full Text] [Related]
10. Low molecular weight heparin for deep vein thrombosis in glioma patients. Schmidt F; Faul C; Dichgans J; Weller M J Neurol; 2002 Oct; 249(10):1409-12. PubMed ID: 12382158 [TBL] [Abstract][Full Text] [Related]
11. Anticoagulant treatment of deep vein thrombosis and pulmonary embolism. Tran H; McRae S; Ginsberg J Cardiol Clin; 2008 May; 26(2):235-50, vi-vii. PubMed ID: 18406997 [TBL] [Abstract][Full Text] [Related]
12. Update in the treatment of venous thromboembolism. Garcia DA; Spyropoulos AC Semin Respir Crit Care Med; 2008 Feb; 29(1):40-6. PubMed ID: 18302085 [TBL] [Abstract][Full Text] [Related]
13. Current management of acute symptomatic deep vein thrombosis. Heit JA Am J Cardiovasc Drugs; 2001; 1(1):45-50. PubMed ID: 14728051 [TBL] [Abstract][Full Text] [Related]
14. The treatment of deep venous thrombosis, including the newer agents. Rectenwald JE; Wakefield TW Dis Mon; 2005; 51(2-3):104-11. PubMed ID: 15900261 [No Abstract] [Full Text] [Related]
15. Out of hospital anticoagulant therapy in patients with acute pulmonary embolism is frequently practised but not perfect. van Bladel ER; Agterof MJ; Frijling BD; van der Griend R; Prins MH; Schutgens RE; Biesma DH Thromb Res; 2010 Dec; 126(6):481-5. PubMed ID: 20888623 [TBL] [Abstract][Full Text] [Related]
17. The venous side: current directions in anticoagulant therapy. Kaatz S J Am Osteopath Assoc; 2000 Nov; 100(11 Suppl):S17-21. PubMed ID: 11191117 [TBL] [Abstract][Full Text] [Related]
18. Treatment of deep vein thrombosis using low-molecular-weight heparins. Groce JB Am J Manag Care; 2001 Nov; 7(17 Suppl):S510-5; discussion S515-23. PubMed ID: 11732662 [TBL] [Abstract][Full Text] [Related]
19. Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins. Siragusa S; Anastasio R; Porta C; Falaschi F; Pirrelli S; Palmieri P; Gamba G; Granzow K; Malato A; Minardi V; Tatoni P; Bressan MA; Mariani G Arch Intern Med; 2004 Dec 13-27; 164(22):2477-82. PubMed ID: 15596639 [TBL] [Abstract][Full Text] [Related]
20. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Kearon C; Kahn SR; Agnelli G; Goldhaber S; Raskob GE; Comerota AJ Chest; 2008 Jun; 133(6 Suppl):454S-545S. PubMed ID: 18574272 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]